ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncolytic Viral Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-10U16018
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncolytic Viral Drugs Market Research Report 2023
BUY CHAPTERS

Global Oncolytic Viral Drugs Market Research Report 2025

Code: QYRE-Auto-10U16018
Report
May 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Rigvir Holding
Shanghai Pharma Sunway Biotech
Daiichi Sankyo Co Ltd

Oncolytic Viral Drugs Market

The global market for Oncolytic Viral Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Oncolytic virus (OV) is a type of virus that can specifically replicate and cause cancer cell apoptosis while sparing normal tissue from being destroyed. Oncolytic virus therapy is a promising cancer treatment method. OVs can be divided into 2 main categories: natural viruses and genetically modified viruses. Naturally occurring OVs include reovirus, Newcastle disease virus (NDV), enterovirus and measles virus (MV), etc., and most OVs have been genetically modified to increase the tropism of the virus to tumor cells and improve virus selection. sexual replication and lytic potential, and enhance host anti-tumor immunity.
North American market for Oncolytic Viral Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oncolytic Viral Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Oncolytic Viral Drugs include Amgen, Inc., Daiichi Sankyo Co., Ltd., Rigvir Holding, Shanghai Pharma Sunway Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncolytic Viral Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Viral Drugs.
The Oncolytic Viral Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncolytic Viral Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Viral Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oncolytic Viral Drugs Market Report

Report Metric Details
Report Name Oncolytic Viral Drugs Market
Segment by Type
  • Natural Virus
  • Genetically Modified Virus
Segment by Application
  • Nasopharyngeal Cancer
  • Melanoma
  • Glioma
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen, Inc., Daiichi Sankyo Co., Ltd., Rigvir Holding, Shanghai Pharma Sunway Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oncolytic Viral Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oncolytic Viral Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Oncolytic Viral Drugs Market report?

Ans: The main players in the Oncolytic Viral Drugs Market are Amgen, Inc., Daiichi Sankyo Co., Ltd., Rigvir Holding, Shanghai Pharma Sunway Biotech

What are the Application segmentation covered in the Oncolytic Viral Drugs Market report?

Ans: The Applications covered in the Oncolytic Viral Drugs Market report are Nasopharyngeal Cancer, Melanoma, Glioma, Other

What are the Type segmentation covered in the Oncolytic Viral Drugs Market report?

Ans: The Types covered in the Oncolytic Viral Drugs Market report are Natural Virus, Genetically Modified Virus

Recommended Reports

Oncology Drugs

Gene Therapy

Viral Therapeutics

1 Oncolytic Viral Drugs Market Overview
1.1 Product Definition
1.2 Oncolytic Viral Drugs by Type
1.2.1 Global Oncolytic Viral Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Natural Virus
1.2.3 Genetically Modified Virus
1.3 Oncolytic Viral Drugs by Application
1.3.1 Global Oncolytic Viral Drugs Market Value by Application (2024 VS 2031)
1.3.2 Nasopharyngeal Cancer
1.3.3 Melanoma
1.3.4 Glioma
1.3.5 Other
1.4 Global Oncolytic Viral Drugs Market Size Estimates and Forecasts
1.4.1 Global Oncolytic Viral Drugs Revenue 2020-2031
1.4.2 Global Oncolytic Viral Drugs Sales 2020-2031
1.4.3 Global Oncolytic Viral Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oncolytic Viral Drugs Market Competition by Manufacturers
2.1 Global Oncolytic Viral Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oncolytic Viral Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oncolytic Viral Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oncolytic Viral Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oncolytic Viral Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncolytic Viral Drugs, Product Type & Application
2.7 Global Key Manufacturers of Oncolytic Viral Drugs, Date of Enter into This Industry
2.8 Global Oncolytic Viral Drugs Market Competitive Situation and Trends
2.8.1 Global Oncolytic Viral Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oncolytic Viral Drugs Players Market Share by Revenue
2.8.3 Global Oncolytic Viral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oncolytic Viral Drugs Market Scenario by Region
3.1 Global Oncolytic Viral Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oncolytic Viral Drugs Sales by Region: 2020-2031
3.2.1 Global Oncolytic Viral Drugs Sales by Region: 2020-2025
3.2.2 Global Oncolytic Viral Drugs Sales by Region: 2026-2031
3.3 Global Oncolytic Viral Drugs Revenue by Region: 2020-2031
3.3.1 Global Oncolytic Viral Drugs Revenue by Region: 2020-2025
3.3.2 Global Oncolytic Viral Drugs Revenue by Region: 2026-2031
3.4 North America Oncolytic Viral Drugs Market Facts & Figures by Country
3.4.1 North America Oncolytic Viral Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oncolytic Viral Drugs Sales by Country (2020-2031)
3.4.3 North America Oncolytic Viral Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oncolytic Viral Drugs Market Facts & Figures by Country
3.5.1 Europe Oncolytic Viral Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oncolytic Viral Drugs Sales by Country (2020-2031)
3.5.3 Europe Oncolytic Viral Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oncolytic Viral Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Oncolytic Viral Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oncolytic Viral Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Oncolytic Viral Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oncolytic Viral Drugs Market Facts & Figures by Country
3.7.1 Latin America Oncolytic Viral Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oncolytic Viral Drugs Sales by Country (2020-2031)
3.7.3 Latin America Oncolytic Viral Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oncolytic Viral Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Oncolytic Viral Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oncolytic Viral Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oncolytic Viral Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oncolytic Viral Drugs Sales by Type (2020-2031)
4.1.1 Global Oncolytic Viral Drugs Sales by Type (2020-2025)
4.1.2 Global Oncolytic Viral Drugs Sales by Type (2026-2031)
4.1.3 Global Oncolytic Viral Drugs Sales Market Share by Type (2020-2031)
4.2 Global Oncolytic Viral Drugs Revenue by Type (2020-2031)
4.2.1 Global Oncolytic Viral Drugs Revenue by Type (2020-2025)
4.2.2 Global Oncolytic Viral Drugs Revenue by Type (2026-2031)
4.2.3 Global Oncolytic Viral Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Oncolytic Viral Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oncolytic Viral Drugs Sales by Application (2020-2031)
5.1.1 Global Oncolytic Viral Drugs Sales by Application (2020-2025)
5.1.2 Global Oncolytic Viral Drugs Sales by Application (2026-2031)
5.1.3 Global Oncolytic Viral Drugs Sales Market Share by Application (2020-2031)
5.2 Global Oncolytic Viral Drugs Revenue by Application (2020-2031)
5.2.1 Global Oncolytic Viral Drugs Revenue by Application (2020-2025)
5.2.2 Global Oncolytic Viral Drugs Revenue by Application (2026-2031)
5.2.3 Global Oncolytic Viral Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Oncolytic Viral Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen, Inc.
6.1.1 Amgen, Inc. Company Information
6.1.2 Amgen, Inc. Description and Business Overview
6.1.3 Amgen, Inc. Oncolytic Viral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen, Inc. Oncolytic Viral Drugs Product Portfolio
6.1.5 Amgen, Inc. Recent Developments/Updates
6.2 Daiichi Sankyo Co., Ltd.
6.2.1 Daiichi Sankyo Co., Ltd. Company Information
6.2.2 Daiichi Sankyo Co., Ltd. Description and Business Overview
6.2.3 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product Portfolio
6.2.5 Daiichi Sankyo Co., Ltd. Recent Developments/Updates
6.3 Rigvir Holding
6.3.1 Rigvir Holding Company Information
6.3.2 Rigvir Holding Description and Business Overview
6.3.3 Rigvir Holding Oncolytic Viral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Rigvir Holding Oncolytic Viral Drugs Product Portfolio
6.3.5 Rigvir Holding Recent Developments/Updates
6.4 Shanghai Pharma Sunway Biotech
6.4.1 Shanghai Pharma Sunway Biotech Company Information
6.4.2 Shanghai Pharma Sunway Biotech Description and Business Overview
6.4.3 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product Portfolio
6.4.5 Shanghai Pharma Sunway Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oncolytic Viral Drugs Industry Chain Analysis
7.2 Oncolytic Viral Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oncolytic Viral Drugs Production Mode & Process Analysis
7.4 Oncolytic Viral Drugs Sales and Marketing
7.4.1 Oncolytic Viral Drugs Sales Channels
7.4.2 Oncolytic Viral Drugs Distributors
7.5 Oncolytic Viral Drugs Customer Analysis
8 Oncolytic Viral Drugs Market Dynamics
8.1 Oncolytic Viral Drugs Industry Trends
8.2 Oncolytic Viral Drugs Market Drivers
8.3 Oncolytic Viral Drugs Market Challenges
8.4 Oncolytic Viral Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amgen Inc
Rigvir Holding
Shanghai Pharma Sunway Biotech
Daiichi Sankyo Co Ltd
List of Tables
 Table 1. Global Oncolytic Viral Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oncolytic Viral Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oncolytic Viral Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oncolytic Viral Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Oncolytic Viral Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oncolytic Viral Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oncolytic Viral Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oncolytic Viral Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oncolytic Viral Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oncolytic Viral Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oncolytic Viral Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Oncolytic Viral Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oncolytic Viral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Viral Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oncolytic Viral Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oncolytic Viral Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Oncolytic Viral Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Oncolytic Viral Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Oncolytic Viral Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Oncolytic Viral Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oncolytic Viral Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Oncolytic Viral Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oncolytic Viral Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Oncolytic Viral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oncolytic Viral Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Oncolytic Viral Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Oncolytic Viral Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oncolytic Viral Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oncolytic Viral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oncolytic Viral Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Oncolytic Viral Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Oncolytic Viral Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oncolytic Viral Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oncolytic Viral Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oncolytic Viral Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Oncolytic Viral Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Oncolytic Viral Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oncolytic Viral Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oncolytic Viral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oncolytic Viral Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Oncolytic Viral Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Oncolytic Viral Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oncolytic Viral Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oncolytic Viral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oncolytic Viral Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Oncolytic Viral Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Oncolytic Viral Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oncolytic Viral Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oncolytic Viral Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Oncolytic Viral Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Oncolytic Viral Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Oncolytic Viral Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Oncolytic Viral Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oncolytic Viral Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oncolytic Viral Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Oncolytic Viral Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Oncolytic Viral Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Oncolytic Viral Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Oncolytic Viral Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Oncolytic Viral Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Oncolytic Viral Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Oncolytic Viral Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Oncolytic Viral Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oncolytic Viral Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oncolytic Viral Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Oncolytic Viral Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Oncolytic Viral Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Oncolytic Viral Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Amgen, Inc. Company Information
 Table 71. Amgen, Inc. Description and Business Overview
 Table 72. Amgen, Inc. Oncolytic Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Amgen, Inc. Oncolytic Viral Drugs Product
 Table 74. Amgen, Inc. Recent Developments/Updates
 Table 75. Daiichi Sankyo Co., Ltd. Company Information
 Table 76. Daiichi Sankyo Co., Ltd. Description and Business Overview
 Table 77. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Daiichi Sankyo Co., Ltd. Oncolytic Viral Drugs Product
 Table 79. Daiichi Sankyo Co., Ltd. Recent Developments/Updates
 Table 80. Rigvir Holding Company Information
 Table 81. Rigvir Holding Description and Business Overview
 Table 82. Rigvir Holding Oncolytic Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Rigvir Holding Oncolytic Viral Drugs Product
 Table 84. Rigvir Holding Recent Developments/Updates
 Table 85. Shanghai Pharma Sunway Biotech Company Information
 Table 86. Shanghai Pharma Sunway Biotech Description and Business Overview
 Table 87. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Shanghai Pharma Sunway Biotech Oncolytic Viral Drugs Product
 Table 89. Shanghai Pharma Sunway Biotech Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Oncolytic Viral Drugs Distributors List
 Table 93. Oncolytic Viral Drugs Customers List
 Table 94. Oncolytic Viral Drugs Market Trends
 Table 95. Oncolytic Viral Drugs Market Drivers
 Table 96. Oncolytic Viral Drugs Market Challenges
 Table 97. Oncolytic Viral Drugs Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oncolytic Viral Drugs
 Figure 2. Global Oncolytic Viral Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oncolytic Viral Drugs Market Share by Type: 2024 & 2031
 Figure 4. Natural Virus Product Picture
 Figure 5. Genetically Modified Virus Product Picture
 Figure 6. Global Oncolytic Viral Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Oncolytic Viral Drugs Market Share by Application: 2024 & 2031
 Figure 8. Nasopharyngeal Cancer
 Figure 9. Melanoma
 Figure 10. Glioma
 Figure 11. Other
 Figure 12. Global Oncolytic Viral Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Oncolytic Viral Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Oncolytic Viral Drugs Sales (2020-2031) & (K Units)
 Figure 15. Global Oncolytic Viral Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 16. Oncolytic Viral Drugs Report Years Considered
 Figure 17. Oncolytic Viral Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Oncolytic Viral Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Oncolytic Viral Drugs Players: Market Share by Revenue in Oncolytic Viral Drugs in 2024
 Figure 20. Oncolytic Viral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Oncolytic Viral Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Oncolytic Viral Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Oncolytic Viral Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. United States Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Oncolytic Viral Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Oncolytic Viral Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Oncolytic Viral Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Oncolytic Viral Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Oncolytic Viral Drugs Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Oncolytic Viral Drugs Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Oncolytic Viral Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Oncolytic Viral Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Oncolytic Viral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Oncolytic Viral Drugs by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Oncolytic Viral Drugs by Type (2020-2031)
 Figure 54. Global Oncolytic Viral Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Oncolytic Viral Drugs by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Oncolytic Viral Drugs by Application (2020-2031)
 Figure 57. Global Oncolytic Viral Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 58. Oncolytic Viral Drugs Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Oncolytic Virus Market Insights Forecast to 2030
Global Oncolytic Virus Therapy Market Research Report 2025
Global Oncolytic Virus Cancer Immunotherapy Market Insights Forecast to 2030
Global Oncolytic Virus Immunotherapy Market Research Report 2024
Global Oncolytic Virus Manufacturing Services Market Research Report 2024
Global Oncolytic Virus Manufacturing and Development Services Market Research Report 2024
Global Vaccinia Virus VACV Service Market Research Report 2024
Global Viral Vector Based Gene Therapy Drugs Market Research Report 2024
Global Viral Vectors Gene Therapy Market Research Report 2025
Global Viral and Non viral Vector Market Research Report 2024
Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Viral Vector Manufacturing for Gene Therapy Market Research Report 2024
Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immunosuppressants in Cancer Therapy Market Research Report 2024
Global Gene Therapy in Oncology Market Research Report 2024
Global Gene Therapy For Cancer Market Research Report 2024
Global Adenovirus Services Market Research Report 2025
Global Cancer Immunosuppressant Treatment Market Research Report 2024
Global Oncology Injection Drug Market Research Report 2025
Global Cancer Immunotherapy Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions